Tylski Perrine, Pina-Jomir Géraldine, Bournaud-Salinas Claire, Jalade Patrice
Service de Physique Médicale et Radioprotection, Hospices Civils de Lyon, Lyon, France.
Service de Médecine Nucléaire, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
EJNMMI Phys. 2021 Mar 31;8(1):33. doi: 10.1186/s40658-021-00378-3.
Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234-1243, 2017). Clinical management of these extravasations requires the preliminary estimation of the dose distribution in the extravasation area. Data are scarce regarding the dose estimation in the literature. This work presents a methodology for estimating the dose distribution after an extravasation occurred in September 2017, in the arm of a patient during a 7.4-GBq infusion of Lutathera ® (AAA).
A local quantification procedure initially developed for renal dosimetry was used. A calibration factor was determined and verified by phantom study. Extravasation volume of interest and its variation in time were determined using 4 whole body (WB) planar acquisitions performed at 2 h (T), 5 h (T), 20 h (T), and 26 h (T) after the beginning of the infusion and three SPECT/CT thoracic acquisitions at T, T, and T. For better estimation of initial extravasation volume, 3 volumes were defined on SPECT images using a 3D activity threshold. Cumulated activities and associated absorbed doses (D, D, D) were calculated in the 3 volumes using the MIRD formalism.
Volumes estimated using 3D threshold were V = 1000 mL, V =400 mL, and V =180 mL. Cumulated activities were evaluated using a monoexponential fit on activities calculated on SPECT images. Estimated local absorbed doses in V, V, and V were D = 2.3 Gy, D = 4.1 Gy, and D = 6.8 Gy. Evolution in time of local activity in the extravasation area was consistent with an effective local half-life (T) of 2.3 h.
Rapid local dose estimation was permitted thanks to knowledge of the calibration factor determined previous to accidental extravasation. Lutathera® lymphatic drainage was quick in the arm (T = 2.3h). Estimated doses were in the lower range of deterministic effects and far under soft tissue necrosis threshold. Thus, no surgical rinse was proposed. The patient did not show any clinical consequence of the extravasation.
用于靶向内放射治疗的放射性药物外渗可导致严重的组织损伤(范德波尔等人,《欧洲核医学与分子影像杂志》44:1234 - 1243,2017年)。这些外渗的临床处理需要初步估计外渗区域的剂量分布。文献中关于剂量估计的数据很少。这项工作提出了一种方法,用于估计2017年9月一名患者在输注7.4GBq的卢加替雷(AAA)期间手臂发生外渗后的剂量分布。
使用最初为肾脏剂量测定开发的局部定量程序。通过体模研究确定并验证了校准因子。在输注开始后2小时(T)、5小时(T)、20小时(T)和26小时(T)进行4次全身(WB)平面采集,并在T、T和T进行3次胸部SPECT/CT采集,以确定感兴趣的外渗体积及其随时间的变化。为了更好地估计初始外渗体积,在SPECT图像上使用三维活性阈值定义了3个体积。使用MIRD形式计算这3个体积中的累积活度和相关吸收剂量(D、D、D)。
使用三维阈值估计的体积为V = 1000 mL、V = 400 mL和V = 180 mL。累积活度通过对SPECT图像上计算的活度进行单指数拟合来评估。V、V和V中估计的局部吸收剂量分别为D = 2.3 Gy、D = 4.1 Gy和D = 6.8 Gy。外渗区域局部活度随时间的变化与2.3小时的有效局部半衰期(T)一致。
由于在意外外渗之前确定了校准因子,因此可以快速进行局部剂量估计。卢加替雷在手臂中的淋巴引流很快(T = 2.3小时)。估计剂量处于确定性效应的较低范围内,远低于软组织坏死阈值。因此,未建议进行手术冲洗。患者未表现出任何外渗的临床后果。